HomeTagsNovartis to buy kidney disease drug maker Regulus in up to $1.7 billion deal

Novartis to buy kidney disease drug maker Regulus in up to $1.7 billion deal
N

Continue reading...

Novartis to buy kidney disease drug maker Regulus in up to...

Novartis to buy kidney disease drug maker Regulus in up to $1.7 billion deal Novartis (NOVN.S), opens new tab has agreed to buy Regulus Therapeutics (RGLS.O), opens...

Subscribe for Exclusive Access

All

Exclusive Content

EXCLUSIVEThe Future of Work: Embracing Automation and Reskilling for a Sustainable...

October 25, 2024

All

Exclusive Content

EXCLUSIVEBeyond Profit: Embracing Corporate Social Responsibility for a Better World

October 25, 2024

All

Exclusive Content

EXCLUSIVEThe Power of Art: How Creativity Transforms Perspectives and Ignites Change

October 25, 2024

All

Exclusive Content

EXCLUSIVEThe Power of Recycling: Transforming Waste into Valuable Resources

October 25, 2024

The World of Health & Medicine News

Three minutes of moderate activity a day may reduce risk of having a cardiovascular event

WHO to back use of weight-loss drugs for adults globally, raises cost issue

AstraZeneca’s ‘smoker’s lung’ therapy meets main goals of late-stage asthma trials

US FDA accepts Novo Nordisk’s application for oral Wegovy for weight loss

Neuralink’s speech restoration device gets FDA’s ‘breakthrough’ tag

Novartis to buy kidney disease drug maker Regulus in up to $1.7 billion deal

UK’s Genus secures FDA approval for PRP gene edit; shares soar

WHO warns Trump cuts put millions of HIV patients at risk

Boehringer drug delivers ‘unprecedented’ result in lung cancer study

US FDA approves J&J’s immune disorder drug

Or continue exploring...

Novartis to buy kidney disease drug maker Regulus in up to $1.7 billion deal
N

Continue reading...

Novartis to buy kidney disease drug maker Regulus in up to...

Subscribe for Exclusive Access

EXCLUSIVEThe Future of Work: Embracing Automation and Reskilling for a Sustainable...

EXCLUSIVEBeyond Profit: Embracing Corporate Social Responsibility for a Better World

EXCLUSIVEThe Power of Art: How Creativity Transforms Perspectives and Ignites Change

EXCLUSIVEThe Power of Recycling: Transforming Waste into Valuable Resources

The World of Health & Medicine News

Or continue exploring...

Novartis to buy kidney disease drug maker Regulus in up to $1.7 billion dealN

Continue reading...

Subscribe for Exclusive Access

.tdi_173{margin-bottom:40px!important} EXCLUSIVEBeyond Profit: Embracing Corporate Social Responsibility for a Better World

.tdi_192{margin-bottom:40px!important} EXCLUSIVEThe Power of Art: How Creativity Transforms Perspectives and Ignites Change

.tdi_211{margin-bottom:40px!important} EXCLUSIVEThe Power of Recycling: Transforming Waste into Valuable Resources

Novartis to buy kidney disease drug maker Regulus in up to $1.7 billion deal
N

EXCLUSIVEBeyond Profit: Embracing Corporate Social Responsibility for a Better World

EXCLUSIVEThe Power of Art: How Creativity Transforms Perspectives and Ignites Change

EXCLUSIVEThe Power of Recycling: Transforming Waste into Valuable Resources